Katherine L Wilson Selected Research

Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy)

2/2012	Ce-emerin and LEM-2: essential roles in Caenorhabditis elegans development, muscle function, and mitosis.
5/2010	Direct actin binding to A- and B-type lamin tails and actin filament bundling by the lamin A tail.
10/2009	Tyrosine phosphorylation of nuclear-membrane protein emerin by Src, Abl and other kinases.
7/2006	Multiple roles for emerin: implications for Emery-Dreifuss muscular dystrophy.
3/2006	Barrier-to-autointegration factor phosphorylation on Ser-4 regulates emerin binding to lamin A in vitro and emerin localization in vivo.
2/2006	Barrier-to-autointegration factor-like (BAF-L): a proposed regulator of BAF.
4/2005	Direct binding of nuclear membrane protein MAN1 to emerin in vitro and two modes of binding to barrier-to-autointegration factor.
1/2005	Nuclear membrane protein emerin: roles in gene regulation, actin dynamics and human disease.
1/2005	A lamin-dependent pathway that regulates nuclear organization, cell cycle progression and germ cell development.
9/2004	The nuclear envelope lamina network has elasticity and a compressibility limit suggestive of a molecular shock absorber.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katherine L Wilson Research Topics

Disease

17	Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy) 02/2012 - 03/2002
7	Laminopathies 01/2017 - 01/2004
5	Progeria (Hutchinson Gilford Syndrome) 01/2017 - 03/2004
4	X-Linked Emery-Dreifuss Muscular Dystrophy 01/2013 - 09/2004
3	Muscular Dystrophies (Muscular Dystrophy) 01/2017 - 01/2006
3	Cardiomyopathies (Cardiomyopathy) 05/2010 - 09/2004
3	Premature Aging 07/2006 - 03/2004
2	Neuralgia (Stump Neuralgia) 06/2021 - 06/2021
2	Lipodystrophy 01/2017 - 05/2010
1	Hepatocellular Carcinoma (Hepatoma) 05/2018
1	familial dilated cardiomyopathy 01/2017
1	Mental Disorders (Mental Disorder) 01/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Insulin Resistance 01/2017
1	Familial Partial Lipodystrophy (Dunnigan Syndrome) 02/2013
1	Neoplasms (Cancer) 01/2012
1	Cerebellar Diseases (Cerebellar Syndrome) 05/2010
1	Contracture 01/2005
1	Retinoblastoma (Glioblastoma, Retinal) 03/2004

Drug/Important Bio-Agent (IBA)

19	emerinIBA 01/2013 - 03/2002
11	Proteins (Proteins, Gene)FDA Link 06/2021 - 04/2003
10	LaminsIBA 01/2017 - 01/2004
6	Lamin Type A (Lamin A)IBA 05/2018 - 06/2003
3	Messenger RNA (mRNA)IBA 06/2021 - 02/2006
2	Sigma-1 ReceptorIBA 06/2021 - 06/2021
2	ChromatinIBA 01/2012 - 01/2005
1	N- (2- (3,4- Dichlorphenyl)ethyl)- N,N',N'- trimethyl- 1,2- ethandiaminIBA 06/2021
1	AcetylglucosamineIBA 05/2018
1	prelamin AIBA 01/2017
1	Intermediate Filament ProteinsIBA 01/2017
1	EnzymesIBA 02/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2013
1	AntigensIBA 01/2012
1	Actins (F Actin)IBA 05/2010
1	lamin CIBA 05/2010
1	Carrier Proteins (Binding Protein)IBA 08/2007
1	Nuclear Proteins (Protein, Nuclear)IBA 04/2005
1	lamina-associated polypeptide 2IBA 03/2004